Skip to content
中文产业新闻评分52Chinese source

阿斯利康 20 亿美元投资 Summit Therapeutics 推进 ivonescimab 联合 ADC 开发

阿斯利康20亿美元投资Summit，携手推进ivonescimab联合ADC开发

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.